{"transactions":[{"id":4618021,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2026-09-15T20:17:32.000Z","date":"2026-09-15","kind":"purchase","planned":false,"acquired":true,"shares":16000,"price":27.95,"value":447200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $27.9496 to $27.95, inclusive. The reporting person undertakes to provide Celsius Holdings, Inc. (\"Celsius\"), any security holder of Celsius, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":2728187,"source":{"system":"sec-edgar","filing":"0001628280-26-062057","document":"wk-form4_1789503449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889279/000162828026062057/wk-form4_1789503449.xml","form_type":"4"}},{"id":4618020,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2026-09-15T20:17:32.000Z","date":"2026-09-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":27.65,"value":553000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $27.60 to $27.70, inclusive. The reporting person undertakes to provide Celsius Holdings, Inc. (\"Celsius\"), any security holder of Celsius, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":2712187,"source":{"system":"sec-edgar","filing":"0001628280-26-062057","document":"wk-form4_1789503449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889279/000162828026062057/wk-form4_1789503449.xml","form_type":"4"}},{"id":726969,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-25T16:07:15.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2026, December 31, 2026, March 31, 2027 and June 30, 2027."}],"balance_after":50000,"derivative":{"exercise_price":0.2,"expiration_date":"2036-06-24","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-26-000008","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000008/primary_doc.xml","form_type":"4"}},{"id":806234,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:21:53.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":true,"shares":2235417,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":12733058,"source":{"system":"sec-edgar","filing":"0001345281-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000004/primary_doc.xml","form_type":"4"}},{"id":806233,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-17T15:21:53.000Z","date":"2026-04-15","kind":"gift","planned":false,"acquired":true,"shares":8966547,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":10497641,"source":{"system":"sec-edgar","filing":"0001345281-26-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000004/primary_doc.xml","form_type":"4"}},{"id":828598,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T19:39:16.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":true,"shares":7392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":1363685,"source":{"system":"sec-edgar","filing":"0001345281-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000001/primary_doc.xml","form_type":"4"}},{"id":828597,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-25T19:39:16.000Z","date":"2026-03-24","kind":"gift","planned":false,"acquired":true,"shares":1356293,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By CDDS 2.0, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person."}],"balance_after":1356293,"source":{"system":"sec-edgar","filing":"0001345281-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528126000001/primary_doc.xml","form_type":"4"}},{"id":865780,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2026-03-03T18:15:25.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":2611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on the first anniversary of the grant date."}],"balance_after":2692187,"source":{"system":"sec-edgar","filing":"0001628280-26-014143","document":"wk-form4_1772579723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000162828026014143/wk-form4_1772579723.xml","form_type":"4"}},{"id":1105415,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T18:12:14.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026."}],"balance_after":50000,"derivative":{"exercise_price":0.3,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528125000009/primary_doc.xml","form_type":"4"}},{"id":1227153,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2025-03-04T17:06:47.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":4865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs fully vest on\nthe first anniversary of the grant date."}],"balance_after":2689576,"source":{"system":"sec-edgar","filing":"0001341766-25-000037","document":"wk-form4_1741126000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000134176625000037/wk-form4_1741126000.xml","form_type":"4"}},{"id":1438105,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-08T15:49:41.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025."}],"balance_after":50000,"derivative":{"exercise_price":0.18,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-24-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528124000004/primary_doc.xml","form_type":"4"}},{"id":1496387,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2024-05-31T16:38:23.000Z","date":"2024-05-29","kind":"gift","planned":false,"acquired":true,"shares":1965988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction represents the transfer of shares made as a gift for no consideration."}],"balance_after":2684711,"source":{"system":"sec-edgar","filing":"0001341766-24-000044","document":"wk-form4_1717187650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000134176624000044/wk-form4_1717187650.xml","form_type":"4"}},{"id":1594758,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value per share","published_at":"2024-03-05T17:57:40.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units (\"RSUs\"), with each RSU providing for the right to receive one share of common stock, par value $0.001 per share, of Celsius Holdings, Inc. The RSUs vest on the first anniversary of the grant date."}],"balance_after":718723,"source":{"system":"sec-edgar","filing":"0001628280-24-009088","document":"wk-form4_1709679443.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000162828024009088/wk-form4_1709679443.xml","form_type":"4"}},{"id":1827177,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-19T19:27:34.000Z","date":"2023-07-18","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024."}],"balance_after":50000,"derivative":{"expiration_date":"2033-07-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528123000001/primary_doc.xml","form_type":"4"}},{"id":1937730,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-27T16:46:13.000Z","date":"2023-01-05","kind":"gift","planned":false,"acquired":true,"shares":232994,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a bona fide gift for no consideration."}],"balance_after":239049,"source":{"system":"sec-edgar","filing":"0001829126-23-002290","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000182912623002290/ownership.xml","form_type":"4"}},{"id":1999067,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-22T16:06:10.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":2200,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted stock units, all of which vested on December 31, 2022."}],"balance_after":6055,"source":{"system":"sec-edgar","filing":"0001829126-23-001632","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000182912623001632/ownership.xml","form_type":"4"}},{"id":2061950,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T17:09:48.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":1105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted 1,105 RSUs for shares of common stock to be issued under the Issuer's 2015 Stock Incentive Plan. The RSUs shall vest on January 1, 2024."}],"balance_after":3855,"source":{"system":"sec-edgar","filing":"0001829126-23-000458","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000182912623000458/ownership.xml","form_type":"4"}},{"id":2226031,"issuer":{"id":8227,"kind":"organization","name":"INTEGRATED BIOPHARMA INC"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T21:33:52.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of each stock option will be the closing price of the Issuer's Common Stock on June 27, 2022, which represents the fifth trading day after the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2022, December 31, 2022, March 31, 2023 and June 30, 2023."}],"balance_after":50000,"derivative":{"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001345281-22-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016504/000134528122000002/primary_doc.xml","form_type":"4"}},{"id":2530434,"issuer":{"id":3658,"kind":"organization","name":"Celsius Holdings, Inc.","symbol":"CELH"},"owners":[{"id":35487,"kind":"person","name":"DeSantis Damon","position":1,"cik":"0001889279","reported_name":"DeSantis Damon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-01T16:53:10.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":2750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person was granted 2,750 restricted stock units (RSU) under the issuer's 2015 Stock Incentive Plan. The RSUs will vest on December 31, 2021. Each RSU represents a right to receive one share of Celsius Holdings, Inc. common stock upon vesting."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001829126-21-013221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1341766/000182912621013221/ownership.xml","form_type":"4"}}]}